OPKO Health Inc
Veridion Score
Composite trend over time
Why is OPK moving today?
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for OPK.
OPK insider activity
OPKO Health Inc
No multi-insider buying cluster in the last 90 days
Net buying: $4.2M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2026-03-20 | PAGANELLI JOHN A | Insider | buy | $1.14 | 10,000 | 394,340 | $11K | SEC Form 4 |
| 2025-11-21 | 2025-11-21 | FROST PHILLIP MD ET AL | Insider | buy | $1.33 | 192,870 | 216,706,448 | $257K | SEC Form 4 |
| 2025-11-21 | 2025-11-21 | FROST PHILLIP MD ET AL | Insider | buy | $1.33 | 191,490 | 216,513,578 | $255K | SEC Form 4 |
| 2025-11-21 | 2025-11-21 | FROST PHILLIP MD ET AL | Insider | buy | $1.32 | 89,375 | 216,322,088 | $118K | SEC Form 4 |
| 2025-11-21 | 2025-11-21 | FROST PHILLIP MD ET AL | Insider | buy | $1.32 | 3,894 | 216,232,713 | $5K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 31 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moOPK contract awards, year to date.
Public federal awards linked to this ticker.
OPK lobbying filings, year to date.
Registered lobbying filings matched to OPKO Health Inc.
GOTHAM GOVERNMENT RELATIONS